Sign in

CIK 0000907654

  • Non-accelerated filer
  • Smaller reporting company

Oruka Therapeutics, Inc.

Sign in to watch
Ticker
ORKA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
363855489
Phone
+1 650-606-7910
Business address
855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
Former names
ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
  1. 4 Open-market sale Chief Operating Officer sold 384 shares at $3.52 ($1,352)
  2. 4 Open-market sale VP, Finance sold 1,114 shares at $3.52 ($3,921)
  3. 4 Open-market sale Chief Operating Officer sold 457 shares at $3.53 ($1,613)
  4. 4 Open-market sale S.V.P., General Counsel sold 458 shares at $3.51 ($1,608)
  5. 4 Open-market sale BRISTOW MICHAEL R sold 752 shares at $3.50 ($2,632)
  6. 4 Open-market sale VP, Finance sold 160 shares at $3.46 ($554)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market sale Chief Operating Officer sold 496 shares at $5.14 ($2,549)
  12. 4 Open-market sale BRISTOW MICHAEL R sold 1,809 shares at $6.33 ($11,451)
  13. 4 Open-market sale VP, Finance sold 476 shares at $6.23 ($2,965)
  14. 4 Open-market sale S.V.P., General Counsel sold 1,129 shares at $6.32 ($7,135)
  15. 4 Open-market sale Chief Operating Officer sold 680 shares at $6.33 ($4,304)
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 11 of 23 · 459 filings